Demetrix Raises $50 Million to Pursue Cannabinoid Biosynthesis

New Cannabis Ventures
By NCV NewswireJul 11, 2019, 12:33 pm154 pts
Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies Funding Round led by Tuatara Capital with Continued Participation by Horizons Ventures EMERYVILLE, Calif., July 11, 2019 /PRNewswire/ — Today, Demetrix Inc., a biotechnology…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Beer Industry Trade Group Calls Out Hemp THC Sector’s ‘Bad Actors’ For Allegedly Marketing To Children 73

Week in Weed – November 8, 2025 69

Harvest strains 2025: The genetics shaping the future of cannabis 65

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.